Harnessing NGLY1 Biology to Cure Disease

Our approach

Discovery of
Critical Pathway

NGLY1 is a highly conserved and powerful gene. Over the last decade, Grace Science has built a global team of bench scientists and clinicians to understand its pathway. Our team has amassed a wealth of unparalleled knowledge.

A significant breakthrough came in 2017, when co-founder Dr. Carolyn Bertozzi connected NGLY1 with multiple cancers and with more common neurodegenerative diseases.

Grace's Story

We’d Like to Hear From You

contact us